lotrafiban has been researched along with arginyl-glycyl-aspartyl-serine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barone, FC; Erhardt, JA; Gabriel, MA; Ohlstein, EH; Parsons, AA; Toomey, JR; Willette, RN; Yue, TL | 1 |
1 other study(ies) available for lotrafiban and arginyl-glycyl-aspartyl-serine
Article | Year |
---|---|
Activation of caspase-3/caspase-3-like activity in rat cardiomyocytes by an RGD peptide, but not the GPIIb/IIIa antagonist lotrafiban.
Topics: Animals; Benzodiazepines; Caspase 3; Caspases; Cells, Cultured; Coumarins; Enzyme Activation; Fibrinolytic Agents; Heart; Myocardium; Oligopeptides; Piperidines; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Rats; Rats, Sprague-Dawley | 2001 |